Zobrazeno 1 - 10
of 16
pro vyhledávání: '"V.R. Mantripragada"'
Publikováno v:
Cytotherapy. 23:S181-S182
Publikováno v:
Cytotherapy. 23:S131-S132
Autor:
Budd A. Tucker, Bradley Hittle, Kimerly A. Powell, V. Luangphakdy, V.R. Mantripragada, George F. Muschler
Publikováno v:
Cytotherapy. 23:S180-S181
Publikováno v:
Cytotherapy. 22:S69-S70
Background & Aim Podoplanin (PDPN) was recently reported as a valuable potential marker for identifying human skeletal stem cells (SSCs). These are a subset of connective tissue progenitors (CTPs), a highly variable, and tissue specific group of cell
Publikováno v:
Cytotherapy. 22:S95-S96
Background & Aim Adult connective tissues contain heterogeneous connective tissue progenitors (CTPs) with the capability to proliferate and differentiate to one or more connective tissue phenotypes. The aims of this study were: 1) Define morphologica
Publikováno v:
Cytotherapy. 22:S94-S95
Background & Aim Mesenchymal stromal cell (MSC) therapies can be greatly advanced by taking control over the source materials, particularly by selection of tissue-specific connective tissue progenitors (CTPs) with preferred biological performance. Th
Publikováno v:
Cytotherapy. 21:S91-S92
Background & Aim Cartilage tissue, one of the most popular sources of tissue for cartilage repair, contains a heterogeneous population of progenitors. However, only a subset of this population possess the significant biological potential to prolifera
Autor:
V.R. Mantripragada, N. Piuzzi, W. Bova, C. Boehm, N. Obuchowski, V. Lefebvre, R. Midura, G. Muschler
Publikováno v:
Osteoarthritis and Cartilage. 27:S39-S40
Purpose: There is a clinical need to better characterize tissue sources being used for stem cell therapies. This study focuses on comparison of cells and connective tissue progenitors (CTPs) derive...
Publikováno v:
Cytotherapy. 20:S58-S59
Autor:
Bradley Hittle, George F. Muschler, V. Luangphakdy, Kimerly A. Powell, B. Handerhan, V.R. Mantripragada
Publikováno v:
Cytotherapy. 21:S91
Background & Aim Induced pluripotent stem (iPS) cells are being developed for a broad range of research and therapeutic applications. However, reprogrammed iPS clones are inevitably heterogeneous. Current value judgements are made by visual inspectio